Less Ads, More Data, More Tools Register for FREE

Pin to quick picksB&M Regulatory News (BME)

Share Price Information for B&M (BME)

Share Price is delayed by 15 minutes
Get Live Data
186.80    0.20 (0.11%)
Bid:
186.40
Ask:
186.60
Spread: 0.20 (0.107%)
Market Cap: £1.88b
BME Live PriceLast checked at - London Stock Exchange

Intraday B&M Share Chart

Trading Statement

28 Jul 2020 07:00

RNS Number : 2196U
B&M European Value Retail S.A.
28 July 2020
 

 

 

 

28 July 2020

B&M European Value Retail S.A.

 

Trading Update

 

 

B&M European Value Retail S.A., ("the Group") the UK's leading general merchandise value retailer, today provides a trading update relating to its Year To Date performance.

 

On 1 July 2020, the Group announced that it had made a strong start to the new financial year and, against a highly uncertain economic backdrop and continued impacts from Covid19, B&M was well placed to continue to grow profitably in the UK and continue to develop and prove the proposition in France.

 

The Group's current expectation for the six months to 26 September 2020 ("H1 FY21") Adjusted EBITDA1 (on a pre-IFRS 16 basis) is that it is likely to be in the range of £250m to £270m. The average analysts' consensus forecast2 for H1 FY21 Adjusted EBITDA1 (on a pre-IFRS 16 basis) is £208.1m.

 

There remains considerable uncertainty in relation to both the progression of Covid-19 and the economic outlook and it is therefore hard to predict trading levels for the second half of the year.

 

The safety of the Group's colleagues and customers remains the key priority whilst working hard to continue to meet customers' needs in these difficult times. A more detailed update at the Half Year Results announcement is scheduled for 12 November 2020.

 

This announcement contains inside information which is disclosed in accordance with the Market Abuse Regulation.

 

1. The Directors consider adjusted EBITDA figures to be more reflective of the underlying business performance of the Group and believe that this measure provides additional useful information for investors on the Group's performance. Adjusting items are the effects of derivatives, one off refinancing fees, foreign exchange on the translation of intercompany balances and the effects of revaluing or unwinding balances related to the acquisition of subsidiaries.

 

2. The consensus estimate for Adjusted EBITDA is based upon the average of 9 analyst publications that provide H1 FY21 estimates.

 

 

B&M European Value Retail S.A.

For further information please contact +44 (0) 151 728 5400 ext 5766

Simon Arora, Chief Executive

Paul McDonald, Chief Financial Officer

Steve Webb, Investor Relations Director

Investor.relations@bandmretail.com

 

Media

For media please contact +44 (0) 207 379 5151

Maitland, Daniel Yea

bmstores-maitland@maitland.co.uk

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTEAKXXADEEEFA
Date   Source Headline
20th Aug 20259:00 amRNSDirector/PDMR Shareholding
14th Aug 20255:30 pmRNSDirector/PDMR Exercise of Share Options
1st Aug 202510:00 amRNSDirector/PDMR Shareholding
30th Jul 20259:00 amRNSDirector/PDMR Shareholding
23rd Jul 20259:01 amRNSResult of EGM
23rd Jul 20259:00 amRNSResult of AGM 22 July 2025
22nd Jul 20254:00 pmRNSTR1 Major Shareholdings in Company
21st Jul 20258:00 amRNSBlock Listing Application
16th Jul 20256:00 pmRNSTR1: Major Shareholding Notification
15th Jul 20257:00 amRNSPositive Quarterly LFL Trading Performance
14th Jul 20255:30 pmRNSBlock Listing Six Monthly Return
3rd Jul 20259:00 amRNSTR1: Major Holdings in Company
3rd Jul 20259:00 amRNSTR1: Major Holdings in Company
27th Jun 202511:00 amRNSTR1: Major Holdings in Company
24th Jun 202510:00 amRNSNotice of FY26 Q1 Trading Statement
19th Jun 20254:30 pmRNSDirector Purchase of Shares
19th Jun 20257:00 amRNSNotice of EGM to approve Migration
19th Jun 20257:00 amRNSPublication of Annual Report and Notice of AGM
17th Jun 20257:00 amRNSCEO Purchase of Shares
12th Jun 20255:00 pmRNSDirector/PDMR Purchase of Shares
12th Jun 202510:30 amRNSDirector Share Options
4th Jun 20257:00 amRNSFY25 Preliminary Results
2nd Jun 20256:24 pmRNSTotal Voting Rights
19th May 20255:30 pmRNSTR1: Major Holdings in Company
15th May 20257:00 amRNSAppointment of Tjeerd Jegen as CEO
30th Apr 20257:00 amRNSDirectorate Change
15th Apr 20257:00 amRNSFY25 Post Close Trading Statement
11th Apr 20259:00 amRNSTR1- Major Shareholding Notification
8th Apr 202511:15 amRNSTR1- Major Shareholding Notification
3rd Apr 20256:15 pmRNSTotal Voting Rights - Correction
1st Apr 202512:30 pmRNSTotal Voting Rights
27th Mar 20254:00 pmRNSTR1 - Major Shareholding Notification
24th Mar 202512:00 pmRNSNotice of FY25 Post Close Trading Statement
27th Feb 20257:45 amRNSDirector/PDMR Purchase of Shares
24th Feb 20257:00 amRNSDirectorate Change and Update on FY25 Guidance
19th Feb 20259:00 amRNSTR1 Major Shareholding Notification
7th Feb 20259:00 amRNSTR1 Major Shareholding Notification
3rd Feb 20255:00 pmRNSTR1 Major Shareholding Notification
30th Jan 20255:30 pmRNSTR1 Major Shareholding Notification
24th Jan 202511:00 amRNSTR1 Major Shareholding Notification
20th Jan 202510:45 amRNSResult of OGM
14th Jan 20255:33 pmRNSBlock Listing Six Monthly Return
13th Jan 20254:00 pmRNSHolding(s) in Company
9th Jan 20257:00 amRNS3rd Quarter Trading Update
18th Dec 20248:31 amRNSNotice of Ordinary General Meeting
17th Dec 20249:15 amRNSBoard Appointment
10th Dec 202410:30 amRNSTiming of Announcement of Q3 Trading Statement
9th Dec 20244:00 pmRNSDirector Purchase of Shares
22nd Nov 20244:02 pmRNSDirector Exercise of Share Options
22nd Nov 20244:00 pmRNSDirector Purchase of Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.